XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	0,069	0,093	29.04.

Realtime

Geld

Brief

Zeit

0,069

0,093

29.04.

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.09.2023

Das Instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023
The instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY is traded cum capital adjustment on 15.09.2023 and ex capital adjustment on 18.09.2023

Das Instrument VRQ FR001400JXA2 VERGNET S.A. EO 2,50 EQUITY wird ex Kapitalmassnahme gehandelt am 15.09.2023
The instrument VRQ FR001400JXA2 VERGNET S.A. EO 2,50 EQUITY is traded ex capital adjustment on 15.09.2023

Das Instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023
The instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY is traded cum capital adjustment on 15.09.2023 and ex capital adjustment on 18.09.2023

Das Instrument 3F5 HK0817039453 CHINA JINMAO HLDGS GR.LTD EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023
The instrument 3F5 HK0817039453 CHINA JINMAO HLDGS GR.LTD EQUITY is traded cum capital adjustment on 15.09.2023 and ex capital adjustment on 18.09.2023

Das Instrument 66Q SE0014262549 LOHILO FOODS AB EQUITY wird ex Kapitalmassnahme gehandelt am 15.09.2023
The instrument 66Q SE0014262549 LOHILO FOODS AB EQUITY is traded ex capital adjustment on 15.09.2023

Das Instrument 2E4 FR0011471135 PHAXIAM THERAPEUT. EO-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023
The instrument 2E4 FR0011471135 PHAXIAM THERAPEUT. EO-,10 EQUITY is traded cum capital adjustment on 15.09.2023 and ex capital adjustment on 18.09.2023

Das Instrument 1QH US87407Q2075 TAKUNA ART NEW DL -,001 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023
The instrument 1QH US87407Q2075 TAKUNA ART NEW DL -,001 EQUITY is traded cum capital adjustment on 15.09.2023 and ex capital adjustment on 18.09.2023

Großer Insider-Report 2024 von Dr. Dennis Riedl

Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.

Hier klicken

Zeit	Aktuelle Nachrichten
Mo	CHINA JINMAO (00817): UNAUDITED KEY FINANCIAL DATA OF A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY FOR THE THREE MONTHS ENDED 31 MARCH 2024
Mo	CHINA JINMAO (00817): POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 29 APRIL 2024
Mo	CHINA JINMAO (00817): VOLUNTARY ANNOUNCEMENT PROGRESS OF THE PROPOSED INCREASE IN SHAREHOLDINGS BY DIRECTORS AND THE MANAGEMENT
Fr	CHINA JINMAO (00817): CONNECTED TRANSACTION UNDER THE LOAN AGREEMENT AND THE MORTGAGE AGREEMENT
Mi	CHINA JINMAO (00817): REQUEST FORMS TO NON-REGISTERED HOLDERS

Zeit

Aktuelle Nachrichten

CHINA JINMAO (00817): UNAUDITED KEY FINANCIAL DATA OF A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY FOR THE THREE MONTHS ENDED 31 MARCH 2024

CHINA JINMAO (00817): POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 29 APRIL 2024

CHINA JINMAO (00817): VOLUNTARY ANNOUNCEMENT PROGRESS OF THE PROPOSED INCREASE IN SHAREHOLDINGS BY DIRECTORS AND THE MANAGEMENT

CHINA JINMAO (00817): CONNECTED TRANSACTION UNDER THE LOAN AGREEMENT AND THE MORTGAGE AGREEMENT

CHINA JINMAO (00817): REQUEST FORMS TO NON-REGISTERED HOLDERS

Zeit	Aktuelle Nachrichten
15.09.23	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.09.2023		Das Instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023 The instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.09.23

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.09.2023

Zeit	Aktuelle Nachrichten
11.04.	NFT Ltd. Announces 1 For 50 Reverse Share Split	Hong Kong, April 11, 2024 (GLOBE NEWSWIRE) -- NFT Ltd. (NYSE American: MI) ("Company" or "NFT", formerly known as Takung Art Co., Ltd.), as an emerging online trading platform operator of international... ► Artikel lesen
18.03.	NFT Ltd - 6-K, Report of foreign issuer
04.03.	NFT Ltd - 6-K, Report of foreign issuer
06.02.	NFT Ltd - 6-K, Report of foreign issuer
11.01.	NFT Ltd - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

11.04.

NFT Ltd. Announces 1 For 50 Reverse Share Split

Hong Kong, April 11, 2024 (GLOBE NEWSWIRE) -- NFT Ltd. (NYSE American: MI) ("Company" or "NFT", formerly known as Takung Art Co., Ltd.), as an emerging online trading platform operator of international...
► Artikel lesen

18.03.

NFT Ltd - 6-K, Report of foreign issuer

04.03.

NFT Ltd - 6-K, Report of foreign issuer

06.02.

NFT Ltd - 6-K, Report of foreign issuer

11.01.

NFT Ltd - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
16.04.	NorAm Drilling AS - Ex cash distribution USD 0.04 today
15.04.	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.04.2024	Das Instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY wird ex Kapitalmassnahme gehandelt am 15.04.2024 The instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY is traded ex capital... ► Artikel lesen
10.04.	NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for April 2024
12.03.	NorAm Drilling AS - Ex cash distribution USD 0.05 today
12.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 12.03.2024	Das Instrument 24T SE0002591420 TOBII AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.03.2024 und ex Kapitalmassnahme am 13.03.2024 The instrument 24T SE0002591420 TOBII AB EQUITY is traded cum... ► Artikel lesen

Zeit

Aktuelle Nachrichten

16.04.

NorAm Drilling AS - Ex cash distribution USD 0.04 today

15.04.

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.04.2024

Das Instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY wird ex Kapitalmassnahme gehandelt am 15.04.2024 The instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY is traded ex capital...
► Artikel lesen

10.04.

NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for April 2024

12.03.

NorAm Drilling AS - Ex cash distribution USD 0.05 today

12.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 12.03.2024

Das Instrument 24T SE0002591420 TOBII AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.03.2024 und ex Kapitalmassnahme am 13.03.2024 The instrument 24T SE0002591420 TOBII AB EQUITY is traded cum...
► Artikel lesen

Zeit	Aktuelle Nachrichten
25.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 25.03.2024	Das Instrument P0X FR001400N1P4 PHARNEXT EO -,10 EQUITY wird ex Kapitalmassnahme gehandelt am 25.03.2024 The instrument P0X FR001400N1P4 PHARNEXT EO -,10 EQUITY is traded ex capital adjustment on 25.03.2024Das... ► Artikel lesen
12.03.	XFRA P0X: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
11.03.	PHARNEXT: Pharnext takes full stock of its operating, strategic and financial situation	PARIS, France, March 11, 2024, 04:30 pm CET - Pharnext SA ( FR001400N1P4 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative... ► Artikel lesen
07.03.	XFRA P0X: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPHARNEXT EO -,20... ► Artikel lesen
28.02.	PHARNEXT: Pharnext progresses in analyzing data from pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease type 1A	PARIS, France, February 28, 2024, 08:30 am CET - Pharnext SA ( FR001400N1P4 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for... ► Artikel lesen

Zeit

Aktuelle Nachrichten

25.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 25.03.2024

Das Instrument P0X FR001400N1P4 PHARNEXT EO -,10 EQUITY wird ex Kapitalmassnahme gehandelt am 25.03.2024 The instrument P0X FR001400N1P4 PHARNEXT EO -,10 EQUITY is traded ex capital adjustment on 25.03.2024Das...
► Artikel lesen

12.03.

XFRA P0X: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

11.03.

PHARNEXT: Pharnext takes full stock of its operating, strategic and financial situation

PARIS, France, March 11, 2024, 04:30 pm CET - Pharnext SA ( FR001400N1P4 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative...
► Artikel lesen

07.03.

XFRA P0X: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPHARNEXT EO -,20...
► Artikel lesen

28.02.

PHARNEXT: Pharnext progresses in analyzing data from pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease type 1A

PARIS, France, February 28, 2024, 08:30 am CET - Pharnext SA ( FR001400N1P4 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for...
► Artikel lesen

Zeit	Aktuelle Nachrichten
15.04.	Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus	The study plans for the enrolment of 12 patients in 5 French clinical centersFirst study results expected in Q3 2024This study will enable an evaluation of the intravenous administration of phages,... ► Artikel lesen
09.04.	Phaxiam Therapeutics S.A.: Monthly information related to total number of voting rights and shares composing the share capital - March 29, 2024
05.04.	Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)	Lyon (France) and Cambridge (MA, US), 5 April 2024 - 6:00pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and... ► Artikel lesen
20.03.	Phaxiam Therapeutics S.A.: PHAXIAM Announces 2023 Full-Year Results and Provides Business Update	Conference call and webcast (English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CET Ongoing clinical efforts boding well to create a global phage-therapy leader in high-value indications First... ► Artikel lesen
11.03.	Phaxiam Therapeutics Says Delisting Of ADSs From Nasdaq Effective

Zeit

Aktuelle Nachrichten

15.04.

Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus

The study plans for the enrolment of 12 patients in 5 French clinical centersFirst study results expected in Q3 2024This study will enable an evaluation of the intravenous administration of phages,...
► Artikel lesen

09.04.

Phaxiam Therapeutics S.A.: Monthly information related to total number of voting rights and shares composing the share capital - March 29, 2024

05.04.

Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)

Lyon (France) and Cambridge (MA, US), 5 April 2024 - 6:00pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and...
► Artikel lesen

20.03.

Phaxiam Therapeutics S.A.: PHAXIAM Announces 2023 Full-Year Results and Provides Business Update

Conference call and webcast (English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CET Ongoing clinical efforts boding well to create a global phage-therapy leader in high-value indications First...
► Artikel lesen

11.03.

Phaxiam Therapeutics Says Delisting Of ADSs From Nasdaq Effective

Zeit	Aktuelle Nachrichten
15.09.23	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.09.2023	Das Instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY wird cum Kapitalmassnahme gehandelt am 15.09.2023 und ex Kapitalmassnahme am 18.09.2023 The instrument P0X FR001400GUN7 PHARNEXT EO -,0002 EQUITY... ► Artikel lesen
12.09.23	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 12.09.2023	The following instruments on XETRA do have their first trading 12.09.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.09.2023 Aktien 1 US4280501085 Hesai Group ADR 2 CA7480331072... ► Artikel lesen
11.09.23	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.09.2023	The following instruments on Boerse Frankfurt do have their last trading day on 11.09.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.09.2023ISIN NameCA68405D1096 OPTIMUM... ► Artikel lesen
11.09.23	XFRA ISIN CHANGE	Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenGG00BMH3TR59 The Schiehallion Fund Ltd. 11.09.2023 GG00BJ0CDD21 The Schiehallion Fund Ltd. 12.09.2023 Tausch 1:0,7601US86804F2020 Super... ► Artikel lesen
11.09.23	XFRA CAPITAL ADJUSTMENT INFORMATION - 11.09.2023	Das Instrument APH0 US03209T2087 AMPIO PHARMAC. NEW -,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 11.09.2023 und ex Kapitalmassnahme am 12.09.2023 The instrument APH0 US03209T2087 AMPIO PHARMAC.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.09.23

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.09.2023

12.09.23

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 12.09.2023

The following instruments on XETRA do have their first trading 12.09.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.09.2023 Aktien 1 US4280501085 Hesai Group ADR 2 CA7480331072...
► Artikel lesen

11.09.23

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.09.2023

The following instruments on Boerse Frankfurt do have their last trading day on 11.09.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.09.2023ISIN NameCA68405D1096 OPTIMUM...
► Artikel lesen

11.09.23

XFRA ISIN CHANGE

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenGG00BMH3TR59 The Schiehallion Fund Ltd. 11.09.2023 GG00BJ0CDD21 The Schiehallion Fund Ltd. 12.09.2023 Tausch 1:0,7601US86804F2020 Super...
► Artikel lesen

11.09.23

XFRA CAPITAL ADJUSTMENT INFORMATION - 11.09.2023

Das Instrument APH0 US03209T2087 AMPIO PHARMAC. NEW -,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 11.09.2023 und ex Kapitalmassnahme am 12.09.2023 The instrument APH0 US03209T2087 AMPIO PHARMAC....
► Artikel lesen

Unternehmen / Aktien	Kurs	%
CHINA JINMAO HOLDINGS GROUP LTD	0,075	+12,88 %
LOHILO FOODS AB	0,123	+0,82 %
NFT LIMITED	3,700	0,00 %
NORAM DRILLING AS	3,480	+1,02 %
PHARNEXT	0,080	-28,83 %
PHAXIAM THERAPEUTICS SA	2,855	+0,18 %
VERGNET SA	0,223	+6,19 %

Unternehmen / Aktien

Kurs

CHINA JINMAO HOLDINGS GROUP LTD

0,075

+12,88 %

LOHILO FOODS AB

0,123

+0,82 %

NFT LIMITED

3,700

0,00 %

NORAM DRILLING AS